Urokinase Other names: U-plasminogen activator Urokinase-type plasminogen activator precursor

Therapeutic indications

Urokinase is indicated for:

Indication

Population group: only adults (18 years old or older)

at least one of
Pulmonary embolism
Acute myocardial infarction
Occlusion of artery
Venous obstruction
Phlebitis and thrombophlebitis of other deep vessels of lower extremities

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adults (18 years old or older)

Retinal vascular occlusions

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Urokinase is contraindicated in the following cases:

Contraindication

at least one of
Bleeding
Arteriovenous malformation of precerebral vessels
Arteriovenous malformation of cerebral vessels
Malignant neoplasms of eye, brain and other parts of central nervous system
Hypertension

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: SYNER-KINASE Powder for solution for injection or infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈